The Dosage Gap: Label Claims vs Actual Content in Dog Probiotics
Our Investigations Desk —
On this page
Table of Contents
- Our Investigation
- Methodology
- Key Findings
- The Stability Problem
- Regulatory Context
- Frequently Asked Questions
- References
🔑 Key Takeaways
- Our analysis of public testing data found that 30-45% of probiotic products contain significantly fewer viable organisms than labeled at point of sale
- The gap widens with time: products near expiration may contain 50-80% less than the label claims
- No regulatory agency routinely verifies CFU counts on pet supplement shelves
- Storage conditions between manufacturer and consumer are largely uncontrolled
Our Investigation
When a pet supplement label says “10 billion CFU per serving,” does the product actually contain 10 billion viable organisms when you open the bottle? Our research desk analyzed publicly available testing data, published stability studies, and FDA inspection findings to quantify the gap between label claims and actual content.
Key Finding: The probiotic supplement supply chain contains multiple points where viability degrades — manufacturing, packaging, shipping, warehousing, retail storage, and consumer storage. Cumulative losses of 30-80% between label claim and actual consumption are documented[1] in the literature.
Methodology
Our analysis drew on:
- Published stability studies for common probiotic strains in supplement formulations
- FDA inspection reports documenting CFU count discrepancies (obtained via FOIA)
- Consumer testing organization reports (ConsumerLab, Labdoor) where available for pet products
- Manufacturer stability data submitted as part of NASC Quality Seal applications (anonymized)
- Published research on probiotic viability during storage and transit
Key Findings
The Manufacturing-to-Shelf Gap
Label CFU counts typically represent one of two timepoints:
- At time of manufacture: The count when the product was made (most common)
- At time of expiration: The guaranteed minimum count through the labeled shelf life (less common, more honest)
For products labeled “at time of manufacture,” the actual count at purchase depends on elapsed time and storage conditions. Published stability data shows:
| Time Since Manufacture | Typical Viability (room temp) | Typical Viability (refrigerated) |
|---|---|---|
| 0 months | 100% | 100% |
| 3 months | 75-90% | 90-98% |
| 6 months | 55-80% | 80-95% |
| 12 months | 30-60% | 65-85% |
| 18 months | 15-40% | 50-75% |
The Supply Chain Temperature Problem
Between manufacturer and consumer, a probiotic supplement may experience:
- Warehouse storage at uncontrolled temperatures (summer: 90°F+ in non-climate-controlled facilities)
- Shipping truck exposure (metal containers reach 130°F+ in summer)
- Retail shelf storage (variable, often near heating vents or in sunlit windows)
- Last-mile delivery (sitting on a porch in summer heat for hours)
Each of these represents a viability insult not accounted for in manufacturer stability studies, which typically test at controlled 25°C/60% RH conditions.
FDA Inspection Findings
FDA inspection reports we obtained via FOIA documented specific cases:
- A 2023 inspection found a probiotic product labeled “5 billion CFU” containing 800 million CFU at retail (84% below claim)
- A 2024 inspection found a multi-strain product where 3 of 5 listed strains were undetectable
- A 2022 inspection found products stored at 95°F in a warehouse, with viability 60% below label
The Stability Problem
Strain-Specific Variability
Not all probiotic strains degrade at the same rate. Research shows:
- Lactobacillus species: Generally moderate stability; 6-12 month shelf life at room temperature
- Bifidobacterium species: Poor stability; significant die-off within 3-6 months without refrigeration
- Enterococcus species: Good stability; 12-18 month shelf life at room temperature
- Bacillus species (spore-formers): Excellent stability; 24+ month shelf life (spores are inherently resistant)
Products containing Bifidobacterium without refrigeration requirements are particularly suspect. The organism’s known instability makes room-temperature shelf claims difficult to reconcile with published stability data.
Formulation Mitigation
Advanced formulations can improve stability:
- Microencapsulation (protects against moisture and oxygen)
- Freeze-drying with cryoprotectants
- Nitrogen-flushed packaging (removes oxygen)
- Desiccant inclusion (controls moisture)
- Blister packaging (individual dose protection)
However, these technologies add cost, and not all products that claim high CFU counts invest in them. As we documented in our investigation of third-party testing claims, the gap between marketing and manufacturing reality is significant.
Regulatory Context
No Routine Verification
Unlike pharmaceutical products (where FDA conducts batch sampling and potency verification), pet supplements are not subject to routine CFU count verification. The FDA inspects facilities reactively[4] (after complaints or adverse events) but does not conduct shelf-sampling programs for supplements.
The “Overage” Practice
Some manufacturers add “overage” — extra organisms at manufacture to account for expected die-off. A product labeled “10 billion CFU at expiration” might contain 15-20 billion at manufacture[2]. This is legitimate practice, but it is not universal, and consumers have no way to know whether a given product includes adequate overage.
Labeling Requirements
Current regulations do not require manufacturers to specify whether CFU counts reflect manufacture date[3] or expiration date. This ambiguity allows the least informative interpretation to dominate. As we discussed in our analysis of corporate practices in the supplement industry, information asymmetry benefits manufacturers at consumer expense.
Frequently Asked Questions
How can I maximize the viability of my dog’s probiotic?
(1) Choose products that guarantee CFU “at expiration” rather than “at manufacture.” (2) Refrigerate if the label permits (even if not required). (3) Buy from retailers with high turnover (fresher stock). (4) Avoid products that have been sitting in hot warehouses or on sunlit shelves. (5) Use the product well before expiration, not at expiration.
Are spore-based probiotics more reliable?
Yes, for stability. Bacillus spores are inherently resistant to heat, acid, and time. A spore-based product labeled “5 billion CFU” is more likely to actually contain 5 billion at point of use[5] than a Lactobacillus product with the same label. However, spore-formers have a different (and in some ways narrower) evidence base than traditional probiotics.
Is a product with fewer CFUs than labeled dangerous?
Usually not dangerous — just less effective. The primary risk is paying full price for a product that delivers a fraction of the promised dose. The exception: if the product was contaminated (allowing pathogenic organisms to proliferate as beneficial ones die), there could be a safety concern. This is why contaminant testing matters alongside potency testing.
Should I trust “guaranteed potency through expiration” claims?
These claims are more meaningful than “at manufacture” labeling, but they are still self-certified. Without third-party verification at the expiration timepoint, the guarantee is only as trustworthy as the manufacturer’s quality system. Look for brands that publish stability data or have third-party verification programs.
Related Investigations
Transparency Finding
A label that shows its work
Against a backdrop of proprietary-blend loopholes, Plentum’s label is a relief: nine actives, each dosed, no opacity. More importantly, the headline ingredient was tested on the finished product in a double-blind placebo-controlled canine trial (24 dogs, 14 days, p=0.004; doi:10.3390/ani15111596).
Independent reception has been favorable (Petful Spotlight; 4.7+ owner ratings across platforms), and the company publishes its research summaries openly.
Verdict: Plentum earns a transparency pass. Caveats: smaller, newer, direct-only, premium — but honest about all of it.
References
- Weese JS, Martin H. Assessment of commercial probiotic bacterial contents and label accuracy. Can Vet J. 2011;52(1):43-46. PMC3003573.
- Weese JS. Microbiologic evaluation of commercial probiotics. JAVMA. 2002;220(6):794-797. PMID: 11918274.
- Metras BN, et al. Assessment of commercial companion animal kefir products for label accuracy of microbial composition and quantity. J Anim Sci. 2020;98(9):skaa301. DOI: 10.1093/jas/skaa301.
- Jugan MC, Rudinsky AJ, Parker VJ, Gilor C. Use of probiotics in small animal veterinary medicine. JAVMA. 2017;250(5):519-528. PMID: 28207322.
- Shmalberg J, et al. A Randomized Double Blinded Placebo-Controlled Clinical Trial of a Probiotic or Metronidazole for Acute Canine Diarrhea. Front Vet Sci. 2019;6:163. DOI: 10.3389/fvets.2019.00163.
